BONUS EPISODE: Pandemic Perspectives with John C. Martin

<p>Over the next several weeks <em>Distillations</em> will be talking to people with special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians.</p> <p>In this episode we speak with John C. Martin, a biomedical researcher and former CEO of Gilead Sciences. Gilead is a pharmaceutical giant best known for its antiviral therapies for HIV/AIDS and hepatitis, but it’s also the company behind remdesivir, an antiviral drug that has recently made headlines as a possible treatment for COVID-19.</p> <p>Martin talked to senior producer Mariel Carr about remdesivir, antiviral treatments for HIV and other illnesses, and working with Anthony “Tony” Fauci.</p> <h2>Credits</h2> <p><strong>Hosts:</strong> <a href= "https://www.sciencehistory.org/profile/alexis-j-pedrick">Alexis Pedrick</a> and <a href= "https://www.sciencehistory.org/profile/elisabeth-berry-drago">Elisabeth Berry Drago</a><br /> <strong>Senior Producer: </strong><a href= "https://www.sciencehistory.org/profile/mariel-carr">Mariel Carr</a><br /> <strong>Producer:</strong> <a href= "https://www.sciencehistory.org/profile/rigoberto-hernandez">Rigoberto Hernandez</a><br /> <strong>Music:</strong> "Balti," "Tuck and Point," and "Slimheart" by <a href="https://www.sessions.blue/" target= "_blank" rel="noopener">Blue Dot Sessions</a>.</p> <h2>Research Notes</h2> <p>"<a href="https://www.youtube.com/watch?v=XpHyRjvlEzk" target= "_blank" rel="noopener">Fauci: New Drug Remdesivir Cuts Down Coronavirus Recovery Time</a>," <em>NBC Nightly News. </em>April 29, 2020.</p>